vimarsana.com

Page 4 - Malaghan Institute News Today : Breaking News, Live Updates & Top Stories | Vimarsana

I deliberately let a two-metre long tapeworm live in my gut for two months, writes DR MICHAEL MOSLEY Here s what it felt like

There has been mounting evidence that worms may hold the secret to reducing chronic inflammation which is linked to dementia, cancer and asthma.

New zealandUnited kingdomEast sussexRobertf kennedy jrJohannes gutenberg university mainzMs societySalford universityNottingham universityMalaghan institute of medical researchUniversity of sussexMalaghan instituteMedical researchInflammatory bowel diseases

She was given a year to live - then this Kiwi-made cancer therapy saved her life

A groundbreaking, home-grown cancer therapy trial just hit another milestone and there are hopes to bring it to Kiwis, writes Jamie Morton. Michele Leggott

New zealand generalNew zealandJamie mortonSylvie whinrayChris jacksonMark fryerRobert weinkoveMichele leggottChina guangzhou institute of biomedicineMalaghan instituteMalaghan institute of medical researchSource malaghan instituteNz cancer societyWellington hospitalKelburn based malaghan instituteMedical research

New Zealand cancer trial: CAR T-cell therapy for lymphoma, leukaemia and myeloma is saving lives

A groundbreaking, home-grown cancer therapy trial just hit another milestone and there are hopes to bring it to Kiwis, writes Jamie Morton. Michele Leggott.

New zealandNew zealand generalSylvie whinrayChris jacksonMichele leggottMark fryerJamie mortonRobert weinkoveChina guangzhou institute of biomedicineSource malaghan instituteNz cancer societyMalaghan instituteMalaghan institute of medical researchWellington hospitalKelburn based malaghan instituteMedical research

Woman gives away Fred Again ticket in charity raffle

A Wellington woman is giving away a Fred Again ticket as a raffle style donation to charity.

Kiera brodieMalaghan instituteFred againVic dealsDonna doolittleAnimal rescueRadio new zealandUblic radioUrrent affairs

Significant Milestone Reached In First NZ CAR T-cell Trial As Preparations Made For Larger Phase 2 Registration Trial

The goal of CAR T-cell cancer therapy becoming a standard of care in New Zealand is another step closer with patient enrolment completed and a total of 30 patients treated within the Malaghan Institute’s ENABLE phase 1 safety trial, says Malaghan .

New zealand generalNew zealandUnited statesRobert weinkoveAmerican society of hematologyMaurice wilkins centreWellington zhaotai therapiesMalaghan institute clinicalMalaghan institute of medical researchMalaghan instituteHunan zhaotai medical group changshaThompson family foundationMalaghan institute wellingtonHealth research councilZealand ministry of businessSignificant milestone reached in first

vimarsana © 2020. All Rights Reserved.